{"id":"https://openalex.org/W2096655765","doi":null,"title":"The inhibitory influence of adiponectin on the growth of the murine endothelial cell line HECa 10 in vitro.","display_name":"The inhibitory influence of adiponectin on the growth of the murine endothelial cell line HECa 10 in vitro.","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W2096655765","mag":"2096655765","pmid":"https://pubmed.ncbi.nlm.nih.gov/19569016"},"language":"en","primary_location":{"id":"pmid:19569016","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19569016","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007984563","display_name":"Joanna Po\u0142owinczak-Przyby\u0142ek","orcid":"https://orcid.org/0000-0002-9293-4710","observed_orcids":["https://orcid.org/0000-0002-9293-4710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanna Po\u0142owinczak-Przyby\u0142ek","raw_affiliation_strings":["Department of the Proliferative Diseases, Regional Oncological Centre, \u0141\u00f3d\u017a. g.m-mucha@wp.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of the Proliferative Diseases, Regional Oncological Centre, \u0141\u00f3d\u017a. g.m-mucha@wp.pl","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040352322","display_name":"Gabriela Me\u0142e\u0144-Mucha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriela Me\u0142e\u0144-Mucha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5931,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.70513597,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"60","issue":"3","first_page":"166","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.06279999762773514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":1.0},{"id":"https://openalex.org/keywords/endothelial-cell-proliferation-inhibition","display_name":"endothelial cell proliferation inhibition","score":0.8690000176429749},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9750000238418579},{"id":"https://openalex.org/keywords/angiogenesis-regulation","display_name":"angiogenesis regulation","score":0.8740000128746033},{"id":"https://openalex.org/keywords/antiangiogenic-factors","display_name":"anti-angiogenic factors","score":0.875},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6224978566169739},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45728322863578796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4192264676094055},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3703174591064453},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3551329970359802},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1660071611404419},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06772693991661072}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018919","descriptor_name":"Neovascularization, Physiologic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052242","descriptor_name":"Adiponectin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D052242","descriptor_name":"Adiponectin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:19569016","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19569016","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endokrynologia Polska","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W169025750","https://openalex.org/W945383526","https://openalex.org/W1178559349","https://openalex.org/W1562891630","https://openalex.org/W1938023575","https://openalex.org/W1977071537","https://openalex.org/W1981261500","https://openalex.org/W1982060996","https://openalex.org/W1985147506","https://openalex.org/W1990840335","https://openalex.org/W1994784206","https://openalex.org/W1997978122","https://openalex.org/W2001727439","https://openalex.org/W2008967025","https://openalex.org/W2010374889","https://openalex.org/W2018803923","https://openalex.org/W2028705933","https://openalex.org/W2034784820","https://openalex.org/W2036767439","https://openalex.org/W2042706232","https://openalex.org/W2047043504","https://openalex.org/W2048034841","https://openalex.org/W2052146004","https://openalex.org/W2065697164","https://openalex.org/W2083461110","https://openalex.org/W2091759162","https://openalex.org/W2095726149","https://openalex.org/W2099259194","https://openalex.org/W2102610155","https://openalex.org/W2107865201","https://openalex.org/W2120977310","https://openalex.org/W2131379009","https://openalex.org/W2138750223","https://openalex.org/W2152757414","https://openalex.org/W2162559503","https://openalex.org/W2162896364","https://openalex.org/W2166370133","https://openalex.org/W2167810530","https://openalex.org/W2169799551","https://openalex.org/W2170886970"],"related_works":["https://openalex.org/W2083461110","https://openalex.org/W2074161892","https://openalex.org/W2023245827","https://openalex.org/W2099259194","https://openalex.org/W7095398580","https://openalex.org/W2008967025","https://openalex.org/W2008647271","https://openalex.org/W2061320049","https://openalex.org/W2040809708","https://openalex.org/W3182917345"],"abstract_inverted_index":{"BACKGROUND:":[0],"Adiponectin,":[1],"a":[2],"peptide":[3],"hormone":[4],"secreted":[5],"from":[6,92,109],"the":[7,21,30,33,50,65,68,96,127,137,148,162,168,171],"adipose":[8],"tissue,":[9],"has":[10],"anti-diabetic,":[11],"anti-atherogenic,":[12],"and":[13,16,77,176,194,223],"anti-inflammatory":[14],"properties":[15],"is":[17],"also":[18],"involved":[19],"in":[20,60,75,147,226],"regulation":[22,228],"of":[23,32,44,53,67,95,103,121,139],"angiogenesis.":[24],"However,":[25],"there":[26],"are":[27],"discrepancies":[28],"among":[29],"results":[31],"published":[34],"data":[35,215],"regarding":[36],"its":[37,181],"pro-":[38],"or":[39,59,158,173],"anti-angiogenic":[40],"properties.":[41],"The":[42,101,119,213],"aim":[43],"our":[45],"study":[46],"was":[47,105,114,124,188],"to":[48,111],"examine":[49],"direct":[51],"effect":[52,102,183,207],"various":[54],"adiponectin":[55,104,135,166,193,218],"concentrations":[56,108,146],"applied":[57],"separately":[58],"combination":[61],"with":[62,151,170],"thalidomide":[63,200],"on":[64,208],"growth":[66,120,138,169,222],"murine":[69,87],"endothelial":[70,88,93,220],"cell":[71,79,89,164,210,221],"line":[72,90,142],"HECa":[73,140],"10":[74,141],"24-":[76],"72-hour":[78,163],"cultures.":[80],"MATERIAL":[81],"AND":[82],"METHODS:":[83],"We":[84,132],"used":[85,115],"immortalized":[86],"received":[91],"cells":[94,123],"mouse":[97],"peripheral":[98],"lymph":[99],"node.":[100],"examined":[106,145],"at":[107,116,143,184],"10(-5)":[110],"10(-12)M.":[112],"Thalidomide":[113],"10(-3)M":[117],"concentration.":[118,186],"HECa10":[122],"assessed":[125],"by":[126],"colorimetric":[128],"Mosmann":[129],"method.":[130],"RESULTS:":[131],"found":[133],"that":[134,217],"inhibited":[136,167],"all":[144],"24-hour":[149],"culture,":[150,165],"moderate":[152],"potency.":[153],"There":[154,187],"were":[155],"no":[156,189],"dose-":[157],"time-response":[159],"effects.":[160],"In":[161,196],"same":[172],"weaker":[174],"potency":[175],"we":[177],"did":[178,202],"not":[179,203],"observe":[180],"inhibitory":[182,206],"10(-12)M":[185],"beneficial":[190],"interaction":[191],"between":[192],"thalidomide.":[195],"this":[197,209],"study,":[198],"however,":[199],"alone":[201],"cause":[204],"any":[205],"line.":[211],"CONCLUSIONS:":[212],"obtained":[214],"show":[216],"inhibits":[219],"may":[224],"participate":[225],"angiogenesis":[227],"as":[229],"an":[230],"endogenous":[231],"antiangiogenic":[232],"factor.":[233]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}